...
首页> 外文期刊>The American Surgeon >Importance of Methicillin-Resistant Staphylococcus aureus Eradication in Carriers to Prevent Postoperative Methicillin-Resistant Staphylococcus aureus Surgical Site Infection
【24h】

Importance of Methicillin-Resistant Staphylococcus aureus Eradication in Carriers to Prevent Postoperative Methicillin-Resistant Staphylococcus aureus Surgical Site Infection

机译:耐甲氧西林金黄色葡萄球菌在携带者中根除的重要性,以预防术后耐甲氧西林金黄色葡萄球菌手术部位感染

获取原文
获取原文并翻译 | 示例
           

摘要

Although infrequent, postoperative methicillin-resistant Staphylococcus aureus (MRSA) surgical site infection (SSI) is associated with significant morbidity and cost. Previous studies have identified the importance of MRSA screening to diminish the risk of postoperative MRSA SSI. The current study quantifies the importance of eradication of the MRSA carrier state to prevent MRSA SSI. Beginning February 2007, all admissions to an 800-bed tertiary care hospital were screened for MRSA by nasal swab using rapid polymerase chain reaction-based testing. Patients found to be nasal carriers of MRSA were treated with 2 per cent mupirocin nasal ointment and 4 per cent chlorhexidine soap before surgery. The subset of patients undergoing procedures that are part of the Surgical Care Improvement Project (SCIP) were followed for MRSA SSI (n = 8980). The results of preoperative MRSA screening and eradication of the carrier state were analyzed. Since the initiation of universal MRSA screening, 11 patients undergoing SCIP procedures have developed MRSA SSI (0.12%). Of these, six patients (55%) had negative preoperative screens. Of the five patients with positive preoperative screens, only one received treatment to eradicate the carrier state. In patients who develop MRSA SSI, failure to treat the carrier state before surgery results in MRSA SSI. [PUBLICATION ABSTRACT]
机译:尽管不常见,但术后耐甲氧西林的金黄色葡萄球菌(MRSA)手术部位感染(SSI)与明显的发病率和成本有关。先前的研究已经确定了MRSA筛查对降低术后MRSA SSI风险的重要性。当前的研究量化了消除MRSA携带者状态对预防MRSA SSI的重要性。从2007年2月开始,使用基于快速聚合酶链反应的检测方法,通过鼻拭子筛查了一家拥有800张床位的三级医院的所有入院患者的MRSA。被发现是MRSA鼻携带者的患者在手术前用2%的莫匹罗星鼻软膏和4%的洗必泰肥皂治疗。 MRSA SSI(n = 8980)接受了作为外科手术改善计划(SCIP)一部分的部分手术患者。分析了术前MRSA筛查和消除携带者状态的结果。自开始进行通用MRSA筛查以来,接受SCIP程序治疗的11例患者已发展出MRSA SSI(0.12%)。其中,有6名患者(55%)术前筛查阴性。术前筛查阳性的5例患者中,只有1例接受了根除载体状态的治疗。在患有MRSA SSI的患者中,手术前未能治疗携带者状态会导致MRSA SSI。 [出版物摘要]

著录项

  • 来源
    《The American Surgeon》 |2011年第1期|p.27-31|共5页
  • 作者单位

    WALTER E. POFAHL, M.D.,* KEITH M. RAMSEY, M.D.,[dagger] DELORES L. NOBLES, M.P.H.,[double dagger]M. KATHY COCHRAN, M.S.,[double dagger] CLAUDIA GOETTLER , M.D.*From the *Division of Clinical Effectiveness, Department of Surgery and the [dagger]Division of Infectious Diseases,Department of Internal Medicine, The Brody School of Medicine at East Carolina University, Greenville,North Carolina, and the [double dagger]Department of Safety and Infection Control, Pitt County Memorial Hospital,Greenville, North CarolinaPresented at the Annual Scientific Meeting and Postgraduate Course Program, Southeastern Surgical Congress, Savannah, GA. February 20-23. 2010.Address correspondence and reprint requests to Walter E. Pofahl. M. D., Department of Surgery, 600 Moye Boulevard, Greenville, NC 27834. E-mail: pofahlw@eeu.edu.,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号